文献速递复苏、休克与脓毒症创伤与烧伤重症综合管理与镇静镇痛

输血量封顶:界定持续大量输血中的死亡率平台期

Cresting mortality: Defining a plateau in ongoing massive transfusion.
PubMed 文献 · J Trauma Acute Care Surg · 2022-04-08
一句话结论创伤大出血患者总输血量在4小时达40.5单位、24小时达52.8单位后,院内死亡率进入平台期,可据此设置复苏暂停点评估后续方案。

本研究基于创伤质量改进数据库2013—2017年成人创伤患者,纳入到达4小时内至少输注1单位浓缩红细胞者,共99,042例,其中4小时和24小时内接受平衡输血(浓缩红细胞:血浆1:1至2:1)者分别为28,891例和30,768例。采用自举法结合多变量泊松回归寻找额外输血不再影响院内死亡率的输血量切点。结果显示总输血量在4小时达40.5单位(95%CI 40-41)、24小时达52.8单位(95%CI 52-53)后死亡率进入平台期;平衡输血队列相应为39单位(95%CI 39-39)和53单位(95%CI 53-53)。作者认为这些总输血量可作为复苏暂停点的标志,用以评估后续治疗计划。

要点

  • 总输血量在4小时超过40.5单位(95%CI 40-41)、24小时超过52.8单位(95%CI 52-53)后,院内死亡率不再随输血量增加而显著变化。
  • 平衡输血(浓缩红细胞:血浆1:1至2:1)队列中,死亡率平台期出现在4小时39单位(95%CI 39-39)和24小时53单位(95%CI 53-53)。
  • 作者认为这些总输血量可作为复苏暂停点的标志,用以评估后续治疗计划。
  • 研究为预后与流行病学分析,证据等级Level III。

适用人群与场景

  • 创伤质量改进数据库中2013—2017年登记的成人创伤患者,且在到达后4小时内至少接受1单位浓缩红细胞输注。

诊断标准与关键阈值

  • 总输血量在4小时达40.5单位(95%CI 40-41)或24小时达52.8单位(95%CI 52-53)后,院内死亡率进入平台期。
  • 平衡输血队列(浓缩红细胞:血浆1:1至2:1)中,总输血量在4小时达39单位(95%CI 39-39)或24小时达53单位(95%CI 53-53)后,院内死亡率进入平台期。

研究设计与关键结果

  • 研究类型为基于创伤质量改进数据库的预后与流行病学分析,总体队列99,042例,其中4小时内接受平衡输血28,891例、24小时内接受平衡输血30,768例。
  • 总体队列院内死亡率在4小时总输血量40.5单位(95%CI 40-41)、24小时总输血量52.8单位(95%CI 52-53)后进入平台期。
  • 平衡输血队列院内死亡率在4小时总输血量39单位(95%CI 39-39)、24小时总输血量53单位(95%CI 53-53)后进入平台期。
  • 多变量泊松回归控制年龄、性别、种族、各身体区域最高简明损伤定级评分、合并症、限制治疗的预先指示及为止血实施的主要手术。

证据类型、等级与局限

  • 证据类型为预后与流行病学分析,证据等级Level III。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为这些总输血量可作为复苏暂停点的标志,用以评估后续治疗计划。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Blood-based balanced resuscitation is a standard of care in massively bleeding trauma patients. No data exist as to when this therapy no longer significantly affects mortality. We sought to determine if there is a threshold beyond which further massive transfusion will not affect in-hospital mortality.

METHODS: The Trauma Quality Improvement database was queried for all adult patients registered between 2013 and 2017 who received at least one unit of blood (packed red blood cell) within 4 hours of arrival. In-hospital mortality was evaluated based on the total transfusion volume (TTV) at 4 hours and 24 hours in the overall cohort (OC) and in a balanced transfusion cohort, composed of patients who received transfusion at a ratio of 1:1 to 2:1 packed red blood cell to plasma. A bootstrapping method in combination with multivariable Poisson regression was used to find a cutoff after which additional transfusion no longer affected in-hospital mortality. Multivariable Poisson regression was used to control for age, sex, race, highest Abbreviated Injury Scale score in each body region, comorbidities, advanced directives limiting care, and the primary surgery performed for hemorrhage control.

RESULTS: The OC consisted of 99,042 patients, of which 28,891 and 30,768 received a balanced transfusion during the first 4 hours and 24 hours, respectively. The mortality rate plateaued after a TTV of 40.5 units (95% confidence interval [CI], 40-41) in the OC at 4 hours and after a TTV of 52.8 units (95% CI, 52-53) at 24 hours following admission. In the balanced transfusion cohort, mortality plateaued at a TTV of 39 units (95% CI, 39-39) and 53 units (95% CI, 53-53) at 4 hours and 24 hours following admission, respectively.

CONCLUSION: Transfusion thresholds exist beyond which ongoing transfusion is not associated with any clinically significant change in mortality. These TTVs can be used as markers for resuscitation timeouts to assess the plan of care moving forward.

LEVEL OF EVIDENCE: Prognostic and epidemiological, Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Quintana MT, Zebley JA, Vincent A, et al. Cresting mortality: Defining a plateau in ongoing massive transfusion. J Trauma Acute Care Surg. 2022. PMID: 35393379. doi:10.1097/TA.0000000000003641

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。